Compare VALN & MAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VALN | MAX |
|---|---|---|
| Founded | 2012 | 2014 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 875.7M | 722.8M |
| IPO Year | 2021 | 2020 |
| Metric | VALN | MAX |
|---|---|---|
| Price | $11.30 | $9.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $15.75 | $14.58 |
| AVG Volume (30 Days) | 17.1K | ★ 1.2M |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 25.81 |
| EPS | N/A | ★ 0.39 |
| Revenue | N/A | ★ $1,113,600,000.00 |
| Revenue This Year | $2.58 | $10.18 |
| Revenue Next Year | $4.43 | $10.51 |
| P/E Ratio | ★ N/A | $25.82 |
| Revenue Growth | N/A | ★ 28.78 |
| 52 Week Low | $5.43 | $7.09 |
| 52 Week High | $12.25 | $13.92 |
| Indicator | VALN | MAX |
|---|---|---|
| Relative Strength Index (RSI) | 57.93 | 50.63 |
| Support Level | $8.37 | $7.09 |
| Resistance Level | $12.22 | $11.20 |
| Average True Range (ATR) | 0.42 | 0.52 |
| MACD | -0.05 | 0.22 |
| Stochastic Oscillator | 59.63 | 71.94 |
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.